###begin article-title 0
Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 232 244 232 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-620W </italic>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes for lymphoid tyrosine phosphatase LYP, involved in the negative regulation of early T-cell activation. An association has recently been reported between the PTPN22-620W functional allele and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA), among other autoimmune diseases. Expected linkage proof for consistency cannot be definitely produced by an affected sib-pair (ASP) analysis. Our aim was therefore to search for linkage evidence with the transmission disequilibrium test.
###end p 2
###begin p 3
###xml 99 106 <span type="species:ncbi:9606">patient</span>
DNA from the French Caucasian population was available for two samples of 100 families with one RA patient and both parents, and for 88 RA index cases from RA ASP families. Genotyping was carried out by PCR-restriction fragment length polymorphism. The analysis was performed using the transmission disequilibrium test, genotype relative risk and ASP-based analysis.
###end p 3
###begin p 4
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">620W </italic>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 290 292 290 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
The transmission disequilibrium test of the PTPN22-620W allele revealed linkage and association for RF+ RA (61% of transmission, P = 0.037). The genotype relative risk showed the risk allele in 34% of RF+ RA patients and in 24% of controls derived from nontransmitted parental chromosomes (P = 0.047, odds ratio = 1.69, 95% confidence interval = 1.03-2.78). The ASP investigation showed no enriched risk allele in RA multiplex families, resulting in a lack of power of ASP analysis, explaining the published negative results.
###end p 4
###begin p 5
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
This study is the first to show linkage of PTPN22 to RF+ RA, consistent with PTPN22 as a new RA gene.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 434 443 434 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Rheumatoid arthritis (RA), the most common autoimmune disease, is thought to be a complex disease in which a combination of risk alleles from different susceptibility genes predisposes to the development of the disease, following exposure to as yet unknown environmental factors. Several genome scans have suggested multiple RA loci [1-8], and recent case-control association studies have suggested new RA genes [9,10]. However, only HLA-DRB1 alleles have been both linked to and associated with RA, fulfilling the criteria for a fully demonstrated genetic factor [11].
###end p 7
###begin p 8
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 193 194 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
A genetic association involving a functional polymorphism of the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene was reported to be associated with rheumatoid factor-positive (RF+) RA, with type 1 diabetes, with systemic lupus erythematosus and with autoimmune thyroid disease [12-19]. The PTPN22 gene encodes for the intracellular tyrosine phosphatase LYP, which acts as a negative regulator of early T-cell activation through binding to the Csk protein [20,21].
###end p 8
###begin p 9
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T</italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">620W </italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The PTPN22 single nucleotide polymorphism (SNP) (1858C/T) (rs 2476601) occurs as a result of an amino acid substitution of arginine for tryptophan at position 620 (R620W), in the P1 proline-rich domain. This domain is involved in the binding to the SH3 domain of Csk. Functional analysis showed that it affects the binding of LYP to Csk, leading to a lack of downregulation of T-cell activation, which is consistent with an increased susceptibility to autoimmunity for the 620W allele [12,14].
###end p 9
###begin p 10
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 272 274 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 356 358 356 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-8</sup>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 699 705 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 724 726 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 806 814 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T/T </italic>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 958 964 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 965 971 965 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1141 1148 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 1164 1166 1164 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1306 1308 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1384 1386 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
The PTPN22-1858T allele has been reported to be associated with RF+ RA in several case-control studies [12,18,19,22]. The first study, performed in a white North American population, reported an association between the PTPN22-1858T allele and RF+ sporadic RA (P = 6.6 x 10-4). This association was replicated in a different sample with multiplex RA cases (P = 5.6 x 10-8), the association being restricted to RF+ RA patients [12]. The second study, also performed in a white North American population, compared the frequency of the PTPN22 risk allele between the Study of New Onset Rheumatoid Arthritis cohort and the control sample of the previous study [12], observing the association between the 1858T allele and early RF+ RA. The study also suggested a stronger association for the homozygous genotype 1858T/T [22]. Three recent case-control studies performed in UK, Spanish and North-American Caucasian populations also found an association between the PTPN22-1858T allele and RA [18,19,23]. In contrast, the Spanish study observed no dose effect of the suspected allele [18]. The UK study found an increased frequency of the suspected PTPN22 allele in the RF+ RA cases and suggested a stronger association for the homozygous genotype [19]. The US study confirmed this association was restricted to RF+ RA and also showed a significantly higher risk for the homozygous genotype [23].
###end p 10
###begin p 11
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 657 664 657 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 741 748 741 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 778 780 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
These findings provide strong evidence for the involvement of PTPN22 in RF+ RA susceptibility [24]. The linkage proof is so far lacking, however, as the linkage analysis of the North American Rheumatoid Arthritis Consortium RA-affected sib-pairs resource for this PTPN22 SNP was inconclusive [12]. The transmission disequilibrium test (TDT), simultaneously investigating linkage and association, is predicted to be more powerful than the affected sib-pair (ASP) analysis in demonstrating linkage for a factor such as PTPN22 [25,26]. Three family-based association and linkage studies using TDT analysis were recently reported, providing linkage evidence of PTPN22 to type 1 diabetes [15,27,28]. The aim of the present study was to test this PTPN22 polymorphism for linkage to RF+ RA in the French Caucasian population, taking advantage of the TDT.
###end p 11
###begin title 12
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 12
###begin title 13
Study design and study population
###end title 13
###begin p 14
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 425 432 <span type="species:ncbi:9606">patient</span>
A TDT linkage study was conducted to investigate the PTPN22-1858C/T SNP in RA for one Caucasian population. RA patients and family members were recruited through a national media campaign in France, which was followed by the selection of individuals who fulfill the American College of Rheumatology (formerly the American Rheumatism Association) 1987 revised criteria for RA [29], according to the physician in charge of the patient. All clinical data were reviewed by rheumatologists from our team (SL, LM or P Fritz). All individuals provided informed consent and the ethics committee of the Hopital Bicetre approved the study.
###end p 14
###begin title 15
Transmission disequilibrium test RA samples
###end title 15
###begin p 16
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 127 134 <span type="species:ncbi:9606">patient</span>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
Inclusion criteria for the two samples of the 100 French Caucasian families investigated here were the participation of one RA patient and both parents, as well as a French Caucasian origin of the family, defined by the four grandparents being French Caucasian. Families with an additional sibling with RA or RA patients who were younger than 18 years old were excluded. RA characteristics of index cases from TDT samples 1 and 2 are summarized in Table 1.
###end p 16
###begin title 17
Affected sib-pair RA sample
###end title 17
###begin p 18
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 757 764 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D1S418 </italic>
###xml 768 774 768 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D1S252</italic>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
The 88 index RA patients from the French Caucasian ASP families that had been analyzed for a refined genome scan were investigated in this study [1]. Inclusion criteria for the sample of 88 families had been the participation of at least two siblings with RA and of French Caucasian origin, with all four grandparents being of European Caucasian origin. Families with RA patients younger than 18 years old were excluded. Of these 88 families, 81 had two affected siblings, six families had three affected siblings and one family had four affected siblings. Characteristics of the 88 RA index cases investigated in this study are summarized in Table 1. All ASP families had been previously genotyped for two microsatellite markers flanking the PTPN22 locus (D1S418 and D1S252) located at approximately -1 and +3 Mb, respectively, on either side of the PTPN22 locus, with heterozygosities of 80% and 81%, respectively [1,30].
###end p 18
###begin title 19
Molecular genotyping methods
###end title 19
###begin p 20
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 90 99 90 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 236 247 236 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*01</italic>
###xml 249 260 249 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*04</italic>
###xml 262 274 262 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*11 </italic>
###xml 278 289 278 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*13</italic>
Genomic DNA was purified from fresh peripheral blood leukocytes by standard methods [31]. HLA-DRB1 typing (Dynal Classic high resolution and Sequence Specific Primers DR low resolution) and subtyping (Dynal Classic high resolution, for HLA-DRB1*01, HLA-DRB1*04, HLA-DRB1*11 and HLA-DRB1*13) were carried out using the PCR sequence-specific primers method (Dynal Biotech, Lake Success, NY, USA).
###end p 20
###begin p 21
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RsAI </italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XcmI </italic>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
Genotyping of the PTPN22-1858C/T SNP was performed by PCR-restriction fragment length polymorphism. The sense and antisense primers were, respectively, 5'-GATAATGTTGCTTCAACGGAATTT-3' and 5'-CCATCCCACACTTTATTTTATACT-3'. The PTPN22-1858C/T transition at codon 620 eliminates a restriction site for RsAI in the 1858T allele. TDT RA sample 1 and sample 2 genotypes were checked with the PCR-restriction fragment length polymorphism using the XcmI enzyme, for which the 1858T allele creates a restriction site. Each genotype was interpreted independently by two of the investigators (EG and PD).
###end p 21
###begin title 22
Rheumatoid factor status
###end title 22
###begin p 23
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
The RF+ status was provided by the presence of at least one positive RF+ result during the disease course, as determined by latex fixation, by Waaler Rose assay or by laser nephelometry. The RF test was performed at least once for all TDT and ASP RA patients. The anti-cyclic citrullinated peptide status of RA patients was not available.
###end p 23
###begin title 24
Hardy-Weinberg equilibrium check
###end title 24
###begin p 25
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
The Hardy-Weinberg equilibrium of the PTPN22-1858C/T polymorphism was investigated using a chi-square test with one degree of freedom.
###end p 25
###begin title 26
Analysis
###end title 26
###begin p 27
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
We planned a linkage test of the PTPN22-1858T allele RA hypothesis, restricted to RF+ RA patients. This hypothesis was first tested using the TDT RA sample 1. In case linkage was observed, or at least suggested, a replication test was planned with the TDT RA sample 2 and a global analysis for all TDT RA families. We also investigated the PTPN22 putative genotype in the index ASP RA sample, taking advantage of the linkage data available at the PTPN22 locus, as previously described [32].
###end p 27
###begin title 28
Test for linkage and association in the TDT RA samples
###end title 28
###begin p 29
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 586 588 586 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Linkage and association analysis were performed using the TDT [33] and the genotype relative risk (GRR) test [34]. The TDT compares the transmission of the SNP alleles from heterozygous parents to affected offspring, with Mendel's law expectation (50%), using a chi-square test with one degree of freedom. Similar to a case-control study, GRR compares the SNP genotypes distribution in RA cases and in 'controls' (controls are derived from nontransmitted parental chromosomes, for each family), using a chi-square test with the appropriate degree of freedom or the Fisher's exact test. P < 0.05 was considered significant.
###end p 29
###begin title 30
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Linkage-based test in the ASP RA sample [32]
###end title 30
###begin p 31
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 537 539 537 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 617 619 617 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Genetic factors are expected to be concentrated in families with multiples RA cases, such as ASP families. Within index RA cases, those sharing identical by descent chromosomes at the PTPN22 locus with their RA affected sib could be expected to concentrate further PTPN22 RA genetic factors. The putative PTPN22 genotypes were compared between the ASP RA index cases, the TDT RA cases and the controls from the TDT RA samples (controls are derived from nontransmitted parental chromosomes). For the linkage-based association test, the RF+ index cases that shared at least one allele identical by descent with their RF+ RA sib (IBD1 or IBD2) were used, taking advantage of the linkage data available at the PTPN22 locus [32].
###end p 31
###begin title 32
Stratified linkage analysis based on the PTPN22-1858C/T genotypes
###end title 32
###begin p 33
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
We conducted a linkage analysis using Allegro 1.1 software [35], taking into account the PTPN22-1858C/T genotypes, to select the subgroup of families with an index carrying the putative genotypes.
###end p 33
###begin title 34
Power calculation
###end title 34
###begin p 35
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 121 123 121 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 332 334 332 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Assuming a PTPN22-1858T allele association similar to that of the North American population (14.8% allele frequency in RF+ RA cases and 8.7% in controls) [12], association analysis of our 100 TDT families (TDT RA sample 1) provides a 95% power to show a suggestion for association and a 53% power to reach statistical significance (P < 0.05). Our sample of 200 TDT families provides a 79% power for significance.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
Hardy-Weinberg equilibrium check
###end title 37
###begin p 38
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
The PTPN22-1858C/T polymorphism was in Hardy-Weinberg equilibrium in the control samples investigated.
###end p 38
###begin title 39
Test for linkage and association in the TDT RA samples
###end title 39
###begin title 40
TDT RA sample 1
###end title 40
###begin p 41
###xml 4 17 4 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 100 102 100 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 310 312 310 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 346 348 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 470 472 470 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 606 619 606 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 627 635 627 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 637 644 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T/T</italic>
###xml 651 653 651 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
The PTPN22-1858T allele was more frequent in the RF+ RA cases than in the controls: 20% versus 11% (P = 0.022, odds ratio [OR] = 2.05, 95% confidence interval [CI] = 1.1-3.8). The allele frequency observed in rheumatoid factor-negative (RF-) RA patients was 16%, compared with 10.5% in the resulting controls (P = 0.52). Significant linkage to RF+ RA was observed with an excess of transmission of the 1858T allele from heterozygous parents to RA cases (66% versus 50%, n = 47, P = 0.029) (Table 2). The GRR analysis revealed a statistically significant increase in the frequency of genotypes carrying the PTPN22-1858T allele (1858C/T + 1858T/T) in RF+ RA cases (35%) compared with controls (21%) (Table 3).
###end p 41
###begin title 42
TDT RA sample 2
###end title 42
###begin p 43
###xml 45 58 45 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 234 236 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
We observed an excess of transmission of the PTPN22-1858T allele to RF+ RA patients that was not significant (56%, P = 0.45) (Table 2). The GRR analysis showed a nonsignificant increase of the genotypes carrying the 1858T allele in RF+ RA patients compared with controls (Table 3).
###end p 43
###begin title 44
Combined analysis of TDT samples
###end title 44
###begin p 45
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 239 241 239 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 295 308 295 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 403 405 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 526 539 526 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 605 607 605 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 657 659 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
No statistically significant difference was observed between samples 1 and 2, allowing pooling for combined analysis. PTPN22 linkage to RF+ RA was significant (T-allele transmission, 61%; n = 90, P = 0.037). By contrast, transmission to RF- RA followed Mendel's law exactly (50%) (Table 2). The PTPN22-1858T allele frequency was significantly increased in RF+ RA compared with controls (19% versus 13%, P = 0.029, OR = 1.62, 95% CI = 1.05-2.50). The GRR analysis showed a significant increase of PTPN22 genotypes carrying the PTPN22-1858T allele in RF+ RA patients compared with controls (34% versus 24%, P = 0.047, OR = 1.69, 95% CI = 1.03-2.78). In the RF- RA patients, genotype frequencies were identical to those of controls, in keeping with the 50% transmission (Table 3).
###end p 45
###begin p 46
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 59 68 59 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0101</italic>
###xml 70 79 70 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0102</italic>
###xml 81 90 81 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0401</italic>
###xml 92 101 92 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0404</italic>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0405</italic>
###xml 114 123 114 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0408</italic>
###xml 125 134 125 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1001</italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 340 355 340 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/C </italic>
###xml 358 373 358 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/T </italic>
No correlation between the HLA-DRB1 shared epitope status (DRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001) and the PTPN22 genotypes in RF+ RA index cases was observed (Table 4). Apart from the RF status, no specific clinical features (erosive disease, age at disease onset) were found to be associated with the PTPN22-1858T/C or PTPN22-1858T/T genotypes (data not shown).
###end p 46
###begin title 47
Linkage-based test in the RA multiplex ASP sample
###end title 47
###begin p 48
###xml 21 34 21 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 299 301 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 372 387 372 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858C/T </italic>
###xml 390 405 390 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/T </italic>
###xml 446 448 446 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
The frequency of the PTPN22-1858T allele was similar in the RF+ ASP RA cases compared with the RF+ TDT RA cases (18% versus 19%). The linkage-based subgroup (IBD1 or IBD2) of RF+ RA index cases with concordant RF+ RA sibs showed no increase in the frequency of the suspected allele, compared with RF+ TDT RA cases. The GRR analysis was consistent with those findings, the PTPN22-1858C/T or PTPN22-1858T/T genotype frequency being equal between RF+ RA ASP index cases and RF+ RA TDT cases (Table 5).
###end p 48
###begin title 49
Stratified linkage analysis at the PTPN22 locus based on the 1858C/T genotypes
###end title 49
###begin p 50
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 90 92 90 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 223 238 223 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858C/T </italic>
###xml 241 256 241 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/T </italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 321 323 321 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Previous linkage analysis of these ASP families had shown no linkage at the PTPN22 locus (P = 0.74) [1]. Stratified linkage analysis in RF+-concordant ASP, even after selection of the families with index cases carrying the PTPN22-1858C/T or PTPN22-1858T/T genotypes, still showed no linkage evidence at the PTPN22 locus (P = 0.69).
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 20 33 20 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 266 279 266 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 325 340 325 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858C/T </italic>
###xml 343 358 343 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/T </italic>
###xml 475 477 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 497 499 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 549 551 549 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T/T </italic>
###xml 636 638 636 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 705 714 705 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
We searched for the PTPN22-1858T allele linkage to RF+ RA using the TDT, which simultaneously tests linkage and association, avoiding the major drawback of inevitable imperfect matching between cases and controls. Here, we provide linkage evidence for RF+ RA to the PTPN22-1858T allele. We also observed association with the PTPN22-1858C/T or PTPN22-1858T/T genotypes and we report for the first time an estimation of the association in the French Caucasian population for RF+ RA (34% versus 24%, P = 0.047, OR = 1.69, 95% CI = 1.03-2.78). In ASP RF+ RA index cases, the 1858C/T or 1858T/T genotype has a similar frequency as the TDT RF+ RA index cases. The association appears to be independent from the HLA-DRB1 shared epitope.
###end p 52
###begin p 53
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Our findings therefore provide linkage evidence in support of PTPN22 as a new RF+ RA genetic factor, concurring with previously reported case-control studies [12,18,19,22,23]. We extend this observation to the French Caucasian population, in which the magnitude of the association is similar.
###end p 53
###begin p 54
###xml 150 163 150 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The linkage evidence provided by this study remains statistically modest. Further linkage studies are needed to definitively establish linkage of the PTPN22-1858T allele to RF+ RA. For the observed transmission disequilibrium of 61%, a TDT sample size of 232 families would be required to obtain, with 80% power, an independent replication of the linkage evidence reported here.
###end p 54
###begin p 55
###xml 52 61 52 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 725 727 725 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 874 875 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 932 933 932 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 963 971 963 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 974 982 974 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T/T </italic>
###xml 730 738 <span type="species:ncbi:9606">patients</span>
Genome scans are popular as they do not require any a priori hypothesis to detect disease loci. They are clearly unable to detect all disease loci, however, especially factors such as PTPN22. The increased power of the TDT over the ASP analysis for such factors was predicted long ago [26]. Our observation of the absence of a major increased frequency of the risk allele in multiplex ASP families when compared with sporadic cases, as reported by Begovich and colleagues [12], allows us to estimate the excess of allele sharing expected in the ASP analysis over the Mendel expectation of 50%. Using the estimation of the divergence from Mendel's law obtained from this study (61% transmission from heterozygous parents to RF+ RA patients, instead of 50%) and the genotype frequencies observed, the allele sharing expected is 52% for all families, 53% for the subgroup of RF+-concordant families and 56% for the small subgroup of RF+-concordant families with the 1858C/T or 1858T/T index case.
###end p 55
###begin p 56
###xml 140 147 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
A huge sample size would therefore be required to demonstrate a significant excess of allele sharing over Mendel's law. In that regard, the PTPN22 situation is similar to that of the insulin gene in type 1 diabetes, for which the discrepancy between numerous association reports and the absence of linkage in ASP analysis was resolved using a TDT-like analysis [36]. This explains the complete absence of linkage evidence that we observed in our ASP analysis, in keeping with the absence of clear ASP linkage reported by Begovich and colleagues [12]. Further analysis using sophisticated software such as GIST might help clarify this point [37].
###end p 56
###begin p 57
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
As indicated by Begovich and colleagues, the chromosome 1 linkage suggestion observed in the ASP analysis of the North American Rheumatoid Arthritis Consortium genome scan is not explained by the findings of the PTPN22 association [12]. New RA genes detected by such linkage suggestions, which could be expected to be stronger RA factors, remain to be discovered. Hence the major interest in genome scan persists, despite the lack of power for some RA genes, such as PTPN22.
###end p 57
###begin p 58
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 182 194 182 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-620W </italic>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 420 427 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 431 440 431 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Interestingly, transmission of the 1858T allele to RF- RA cases precisely followed Mendel's law, with genotype frequencies identical to controls, strengthening the evidence that the PTPN22-620W role is restricted to RF+ RA [12,19,22,23]. PTPN22 is probably the first example of a fully confirmed RA gene involved specifically in a precise aspect of RA clinical heterogeneity (RF+ RA). The absence of correlation between PTPN22 and HLA-DRB1 genotypes suggests that both RA genes could be involved in distinct gene combinations predisposing to RA, providing the first example of a clear genetic heterogeneity in RA.
###end p 58
###begin p 59
Because the association is relatively modest, no genetic testing would be clinically indicated. Instead, the clinical relevance of the finding is likely to come through the better understanding of RA pathophysiology. It may lead to new therapeutic targets, aiming at the cause of RA, possibly shared by other autoimmune diseases.
###end p 59
###begin p 60
###xml 74 87 74 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">620W </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 384 397 384 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
Interestingly, all autoimmune diseases reported to be associated with the PTPN22-1858T allele are characterized by the production of autoantibodies [12-14,16,22], suggesting that the 620W variant of LYP could be implicated not only in T-cell activity regulation, but also in B-cell autoreactivity [24]. It will consequently be of major interest to test further for association of the PTPN22-1858T allele in RA families with a clustering of multiple autoimmune diseases to measure precisely this association with each disease [38-41].
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 65 78 65 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 220 227 220 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
Our findings provide linkage evidence for the involvement of the PTPN22-1858T allele in RF+ RA genetic susceptibility, in the French Caucasian population, independent of HLA-DRB1. This is in keeping with the proposal of PTPN22 as a new RA susceptibility gene.
###end p 62
###begin title 63
Abbreviations
###end title 63
###begin p 64
ASP = affected sib-pair; GRR = genotype relative risk; PCR = polymerase chain reaction; RA = rheumatoid arthritis; RF = rheumatoid factor; SNP = single nucleotide polymorphism; TDT = transmission disequilibrium test.
###end p 64
###begin title 65
Competing interests
###end title 65
###begin p 66
The author(s) declare that they have no competing interests.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
###xml 284 292 <span type="species:ncbi:9606">patients</span>
PD and SG carried out the molecular genetic studies. LM, EP-T, EG, CP, SL and FC performed acquisition of the data. PD, SG, LM, CP, BP and FC analyzed and interpreted the data. LM, SL and TB made a substantial contribution to the acquisition of clinical data and the follow-up of the patients. All authors read and approved the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
###xml 22 30 <span type="species:ncbi:9606">patients</span>
The authors thank the patients, their families, their physicians and Dr P Fritz (Centre Viggo-Petersen, Hopital Lariboisiere, Paris, France) for their participation. For funding, the authors thank Association Francaise des Polyarthritiques, Association Rhumatisme et Travail, Association Polyarctique and Groupe Taitbout, Association de Recherche pour la Polyarthrite, Societe Francaise de Rhumatologie, Genopole, Conseil Regional Ile de France, Faculte de Medecine Lariboisiere Saint-Louis and Ministere de la Recherche et de l'Enseignement Superieur. Institutional support from Shering-Plough, Amgen, Pfizer and Wyeth was gratefully received. The authors thank Dr JF Prudhomme, Dr C Bouchier and Professor J Weissenbach at Genethon and Dr C De Toma, MF Legrand and Professor G Thomas at Fondation Jean Dausset-CEPH for technical support. They also thank M Dieude and C Robinson for critical reading of the manuscript (Hopital Notre-Dame, Montreal, Quebec, Canada).
###end p 70
###begin article-title 71
Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates
###end article-title 71
###begin article-title 72
Identification of the gene loci that predispose to rheumatoid arthritis
###end article-title 72
###begin article-title 73
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
###end article-title 73
###begin article-title 74
Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families
###end article-title 74
###begin article-title 75
Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites
###end article-title 75
###begin article-title 76
Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom
###end article-title 76
###begin article-title 77
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases
###end article-title 77
###begin article-title 78
Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs
###end article-title 78
###begin article-title 79
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
###end article-title 79
###begin article-title 80
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis
###end article-title 80
###begin article-title 81
The genetics revolution and the assault on rheumatoid arthritis
###end article-title 81
###begin article-title 82
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
###end article-title 82
###begin article-title 83
###xml 90 95 <span type="species:ncbi:9606">human</span>
Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE
###end article-title 83
###begin article-title 84
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
###end article-title 84
###begin article-title 85
Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus
###end article-title 85
###begin article-title 86
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease
###end article-title 86
###begin article-title 87
A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families
###end article-title 87
###begin article-title 88
Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus
###end article-title 88
###begin article-title 89
Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect
###end article-title 89
###begin article-title 90
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells
###end article-title 90
###begin article-title 91
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase
###end article-title 91
###begin article-title 92
###xml 122 130 <span type="species:ncbi:9606">patients</span>
A functional polymorphism of PTPN22 associates with seropositive but not seronegative rheumatoid arthritis in a cohort of patients with new onset RA (SONORA) [abstract]
###end article-title 92
###begin article-title 93
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status
###end article-title 93
###begin article-title 94
PTPN22 and autoimmune disease
###end article-title 94
###begin article-title 95
The TDT and other family-based tests for linkage disequilibrium and association
###end article-title 95
###begin article-title 96
###xml 41 46 <span type="species:ncbi:9606">human</span>
The future of genetic studies of complex human diseases
###end article-title 96
###begin article-title 97
Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study
###end article-title 97
###begin article-title 98
Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population
###end article-title 98
###begin article-title 99
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 99
###begin article-title 100
###xml 35 40 <span type="species:ncbi:9606">human</span>
A comprehensive genetic map of the human genome based on 5,264 microsatellites
###end article-title 100
###begin article-title 101
Molecular Cloning
###end article-title 101
###begin article-title 102
Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity
###end article-title 102
###begin article-title 103
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM)
###end article-title 103
###begin article-title 104
Estimating genotype relative risks
###end article-title 104
###begin article-title 105
Allegro, a new computer program for multipoint linkage analysis
###end article-title 105
###begin article-title 106
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility
###end article-title 106
###begin article-title 107
Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST)
###end article-title 107
###begin article-title 108
No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome
###end article-title 108
###begin article-title 109
Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes
###end article-title 109
###begin article-title 110
Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene
###end article-title 110
###begin article-title 111
Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset
###end article-title 111
###begin title 112
Figures and Tables
###end title 112
###begin p 113
Characteristics of rheumatoid arthritis (RA) index cases from the investigated samples
###end p 113
###begin p 114
TDT, transmission disequilibrium test; ASP, affected sib-pair
###end p 114
###begin p 115
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 76 1 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001</italic>
aDRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001.
###end p 115
###begin p 116
###xml 24 37 24 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T </italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Linkage analysis of the PTPN22-1858T allele to rheumatoid factor-seropositive (RF+) rheumatoid arthritis (RA) using the transmission disequilibrium test (TDT)
###end p 116
###begin p 117
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 82 90 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
RF-, seronegative for rheumatoid factor. Transmission, percentage of heterozygous 1858C/T parents transmitting the 1858T allele. The plan was to test the hypothesis for RF+ RA; analysis for all RA and RF- RA were provided for the discussion.
###end p 117
###begin p 118
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T </italic>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Association of PTPN22 genotypes carrying the 1858T allele and rheumatoid factor-seropositive (RF+) rheumatoid arthritis (RA)
###end p 118
###begin p 119
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
RF-, seronegative for rheumatoid factor.
###end p 119
###begin p 120
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 80 95 80 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858T/T </italic>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
aFollowing data previously reported in RA and because of the infrequency of the PTPN22-1858T/T genotype, it was combined with the 1858C/T genotype for the analysis.
###end p 120
###begin p 121
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bControls derived from nontransmitted parental chromosomes.
###end p 121
###begin p 122
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858 C/T </italic>
###xml 56 65 56 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
PTPN22-1858 C/T genotypes distribution according to the HLA-DRB1 shared epitope (SE)
###end p 122
###begin p 123
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*SE/SE</italic>
###xml 37 50 37 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*SE/X</italic>
###xml 72 84 72 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*X/X</italic>
HLA-DRB1*SE/SE, two shared epitopes; HLA-DRB1*SE/X, one shared epitope; HLA-DRB1*X/X, zero shared epitope.
###end p 123
###begin p 124
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-1858C/T </italic>
PTPN22-1858C/T genotypes frequencies in the affected sib-pair (ASP) rheumatoid arthritis (RA) sample
###end p 124
###begin p 125
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
RF+, seropositive for rheumatoid factor; IBD1 or IBD2, index sharing 1 or 2 identical by descent allele with the RA sib.
###end p 125
###begin p 126
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858T/T </italic>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1858C/T </italic>
aFollowing data previously reported in RA and because of the infrequency of the PTPN22-1858T/T genotype, it was combined with the 1858C/T genotype for the analysis.
###end p 126
###begin p 127
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bControls derived from all non transmitted parental chromosomes.
###end p 127

